Peruvoside
|  | |
| Clinical data | |
|---|---|
| ATC code | C01AX02 (WHO) | 
| Identifiers | |
| 
 | |
| Synonyms | (3S,5R,10R,13R,14S,17R)- 3-[(2S,5R)- 3,5-dihydroxy- 4-methoxy- 6-methyloxan- 2-yl]oxy- 14-hydroxy- 13-methyl- 17-(5-oxo-2H-furan-3-yl)- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthrene- 10-carbaldehyde | 
| CAS Number | 1182-87-2  | 
| PubChem (CID) | 14449 | 
| ChemSpider | 16498835  | 
| ChEMBL | CHEMBL1075790  | 
| ECHA InfoCard | 100.013.327 | 
| Chemical and physical data | |
| Formula | C30H44O9 | 
| Molar mass | 548.665 g/mol | 
| 3D model (Jmol) | Interactive image | 
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Peruvoside (or cannogenin thevetoside) is a cardiac glycoside[1] for heart failure.[2]
It is derived from Cascabela thevetia (Thevetia neriifolia).[2]
References
- ↑ Arora, R. B.; Rangaswami, S. (1972). Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia neriifolia Juss: Chemical, Pharmacological, and Clinical Studies. New Delhi, India: Thomson. LCCN 78900408.
- 1 2  Bhatia, M. L.; Manchanda, S. C.; Roy, S. B. (1970). "Haemodynamic Studies with Peruvoside in Human Congestive Heart Failure". British Medical Journal. 3 (5725): 740–743. doi:10.1136/bmj.3.5725.740. PMC 1701679 . PMID 4919553. . PMID 4919553.
This article is issued from Wikipedia - version of the 6/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.